Tag: LSPA

Online Simulation Model to Estimate the Total Costs of Tobacco Product Waste in Large U.S. Cities
July 1, 2020 - 4:42 pm, by
Tobacco product waste (TPW) is one of the most ubiquitous forms of litter, accumulating in large amounts on streets, highways, sidewalks, beaches, parks, and other public places, and flowing into storm water drains, waste treatment plants, and solid waste collection facilities.
Telehealth and Telemedicine in the Post-Pandemic Era
June 18, 2020 - 12:42 pm, by
In many ways the arrival of the COVID-19 pandemic globally was met with sub-optimal levels of preparedness on the part of health care providers and provider systems, such as integrated delivery networks (IDNs).
Moving Beyond ‘Lives-Saved’ From COVID-19
May 15, 2020 - 4:51 pm, by
This blog covers the presentation given as part of the ISPOR pre-conference plenary session on HEOR in the era of COVID-19 which was held on 14 May 2020.
Economic Cycles and Product Development in Life Sciences
May 11, 2020 - 4:33 pm, by
Economic Cycles and Product Development in Life Sciences May 11, 2020 By John Schneider, PhD and Mirela Sima, MD, MBA The humanistic and economic consequences of the 2020 COVID-19 pandemic will not be completely understood for years. The humanistic toll has been well documented; as of early May 2020, the global death toll attributable to...
Electronic Medical Records: Potential Issues in Litigation and Biomedical Research
April 27, 2020 - 12:06 pm, by
In this blog entry we explore some of the potentially important issues surrounding the role of EMRs in litigation, where the discovery of medical documents and records increasing involves digitally stored data.[1-4]
COVID-19: Update on Epidemiology & Costs
April 14, 2020 - 11:55 am, by
We define epidemiology broadly, including an up-to-date review of the key published medical literature on COVID-19. Following that, our discussion of costs focuses in part on the direct medical costs (which probably for good reasons has been relatively under-reported) and in part on the broader costs to the economy.
The Coronavirus: How Bad is it, Really?
March 13, 2020 - 4:06 pm, by
By: The Avalon Health Economics Team March 13, 2020 Within a few months we’ve gone from worrying about holiday shopping to worrying about global pandemics and watching the world shut down around us. It started with news from China on the rapid spread of an insidious virus initially called a coronavirus.[1] Once the virus was...
What is the Reasonable Value of Future Medical Care?
February 10, 2020 - 1:49 pm, by
Cara Scheibling and John Schneider, PhD February 7, 2020 A common challenge in economics and business is determining the fair-market value of products and services that have not yet “entered” the market.  If consumers have not yet signaled a “willingness to pay” for the product or service, it is difficult to predict the fair market...
Healthcare Use Cases for Blockchain Technology
June 19, 2019 - 2:38 pm, by
This blog was written by John Schneider, PhD, Katherine Dick, Cara Scheibling Recently, the crypto-currency company Bitcoin has been in the news, mainly for its combination of volatility in valuation coupled with its impenetrable technological foundation.  The virtual currency is perhaps the most well-known application of a technology now commonly referred to as “blockchain.”[1] Each...
Will an Unravelling of the Affordable Care Act Result in Meaningful Organizational Changes in U.S. Medical Care? Implications for Economic Evaluation of Drugs & Devices
December 6, 2016 - 3:34 pm, by
In recent years, there has been a shift in U.S. health care markets to a broader, population-based perspective when assessing the costs and benefits of medical innovation. Cost effectiveness analysis and budget impact analysis results can look quite different when viewed from the perspective of a health system or an accountable care organization, and can...
Do NOT follow this link or you will be banned from the site!